| HOME >> BIOLOGY >> TECHNOLOGY |
Cash and cash equivalents $25,686,189 $24,602,202
Prepaid and other current assets 46,459 5,210
Investment in marketable securities -- 628,585
Total current assets 25,732,648 25,235,997
Investment in other ventures 183,416 173,427
Patents, net 572,443 637,267
Total assets $26,488,507 $26,046,691
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accrued expenses and other current
liabilities $94,612 $61,307
Total current liabilities 94,612 61,307
Commitments
Stockholders' equity:
Common stock 132,857 132,857
Additional paid-in capital 59,844,355 59,844,355
Accumulated deficit (33,283,242) (33,183,960)
Accumulated other comprehensive
(loss) income -- (507,793)
Treasury stock (300,075) (300,075)
Total stockholders' equity 26,393,895 25,985,384
Total liabilities and
stockholder's equity $26,488,507 $26,046,691
CADUS CORPORATION
Condensed Consolidated Statements of Income
(Unaudited)
Three Months Ended
September 30,
2007 2006
License and maintenance fees $- $-
To
'/>"/>
| SOURCE Cadus Corporation Copyright©2007 PR Newswire. All rights reserved |